Biopharmaceuticals
Licensing
News Release - November 27, 2006
Biota and Boehringer Ingelheim Complete US$102 Million License for HCV Program
Source: Biota Holdings Limited
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.